Virus-like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development.
- Published in:
- Biologics, 2022, v. 2, n. 4, p. 226, doi. 10.3390/biologics2040018
- By:
- Publication type:
- Article
Works matching IS 26738449 AND DT 2022 AND VI 2 AND IP 4
Results: 2
1
2
Real-World Effectiveness and Safety of SDZ-ADL (Adalimumab Biosimilar) in Patients with Psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).
- Published in:
- Biologics, 2022, v. 2, n. 4, p. 213, doi. 10.3390/biologics2040017
- By:
- Publication type:
- Article